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Botulinum NeuroToxin-A (BoNT-A) injections to the medial gastrocnemius (MG) and
lower-leg casts are commonly combined to treat ankle equinus in children with spastic
cerebral palsy (CP). However, the decomposed treatment effects on muscle or tendon
structure, stretch reflexes, and joint are unknown. In this study, BoNT-A injections to
the MG and casting of the lower legs were applied separately to gain insight into
the working mechanisms of the isolated treatments on joint, muscle, and tendon
levels. Thirty-one children with spastic CP (GMFCS I-III, age 7.4 ± 2.6 years) received
either two weeks of lower-leg casts or MG BoNT-A injections. During full range of
motion slow and fast passive ankle rotations, joint resistance and MG stretch reflexes
were measured. MG muscle and tendon lengths were assessed at resting and at
maximum dorsiflexion ankle angles using 3D-freehand ultrasound. Treatment effects
were compared using non-parametric statistics. Associations between the effects on
joint andmuscle or tendon levels were performed using Spearman correlation coefficients
(p < 0.05). Increased joint resistance, measured during slow ankle rotations, was not
significantly reduced after either treatment. Additional joint resistance assessed during
fast rotations only reduced in the BoNT-A group (−37.6%, p = 0.013, effect size =
0.47), accompanied by a reduction in MG stretch reflexes (−70.7%, p = 0.003, effect
size = 0.56). BoNT-A increased the muscle length measured at the resting ankle angle
(6.9%, p= 0.013, effect size= 0.53). Joint angles shifted toward greater dorsiflexion after
casting (32.4%, p = 0.004, effect size = 0.56), accompanied by increases in tendon
length (5.7%, p = 0.039, effect size = 0.57; r = 0.40). No associations between the
changes in muscle or tendon lengths and the changes in the stretch reflexes were found.
We conclude that intramuscular BoNT-A injections reduced stretch reflexes in the MG
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accompanied by an increase in resting muscle belly length, whereas casting resulted in
increased dorsiflexion without any changes to the muscle length. This supports the need
for further investigation on the effect of the combined treatments and the development
of treatments that more effectively lengthen the muscle.
Keywords: cerebral palsy, tendon length, muscle length, spasticity, hyper-resistance, casting, Botulinum
NeuroToxin, muscle stretch reflex
INTRODUCTION
Cerebral palsy (CP), the most common childhood disability,
is caused by an injury to the developing brain that occurs
prior to, or shortly after, birth. In case of spastic CP, disturbed
muscle innervation and biomechanical loading is combined with
progressively worsening muscle contractures and joint hyper-
resistance to movement. In the ankle joint, this hyper-resistance
impairs the joint’s passive range of motion (ROM), resulting in
gait impairments such as equinus or excessive knee flexion (1).
Numerous studies have tried to establish the mechanisms that
contribute to the development of ankle joint hyper-resistance in
spastic CP. Recent literature indicates that hyperactive stretch
reflexes, commonly labeled as spasticity, are considered to
have less impact (2, 3). Instead, alterations such as reduced
muscle volume and atrophy, cellular and genetic factors
have been related to the increased joint resistance (4–6).
Despite the likelihood of multifactorial contributions, the most
common non-surgical treatment for joint hyper-resistance is
intramuscular injection of Botulinum NeuroToxin-A (BoNT-
A) which, mainly targets hyperactive stretch reflexes by causing
temporary muscle paralysis. There is no known effect of BoNT-A
in treating the non-neural components of joint hyper-resistance.
The effectiveness of BoNT-A in correcting gait deviations,
and passive joint ROM on the short-term, has been shown
to improve when BoNT-A is combined with casting (7–9).
The rational of this treatment combination is that paralysis,
followed by passive immobilization in a neutral position,
results in tissue elongation through physiological adaptation
to prolonged stretch. However, few clinical studies reported
the effects of BoNT-A treatment at the muscle level (10–18).
Synthesis of existing clinical studies that include post-treatment
assessment of muscle morphology is hindered by methodological
differences between studies and lack of normalization to account
for natural muscle growth. Therefore, results are inconclusive
and whether the improved joint ROM occurs due to muscle
remodeling or at the expense of other soft tissues, is not well-
understood (19).
Given the frequent use of BoNT-A and casting in clinical
practice, and the current uncertainties about their effect
on muscle, more research is required. Knowledge of the
working mechanism of the treatments will help understand
how to combine them more efficiently. This will support the
development of individually tailored treatments, where BoNT-
A and casting are prescribed according to individually assessed
causes of joint hyper-resistance. As a first step toward such
patient-tailored medicine, careful assessment of the individual
effects of BoNT-A and casting on different levels, ranging
from joint to muscle and tendon, is required. The aim of
the current study is to contribute to the understanding of
the individual mechanisms by comprehensively evaluating the
separate short-term effects of BoNT-A and lower-leg casting
on ankle joint hyper-resistance, plantar flexor stretch reflexes,
and muscle-tendon complex lengths. Additionally, the effects
between the two treatments will be compared and the relations
between treatment effects at the different levels are explored
within each treatment group. It is hypothesized that BoNT-
A will reduce hyperactive stretch reflexes, whereas casting
will reduce the joint hyper-resistance by lengthening the
muscle and tendon. Furthermore, any changes that occur
at the joint level will be more related to alterations in




Children with spastic CP, aged between 4 and 17 years,
were recruited from the Clinical Motion Laboratory of the
University Hospital Pellenberg (Belgium), and included when
the multidisciplinary clinical team concluded that there was an
indication for BoNT-A treatment of the medial gastrocnemius
(MG) and casting of their ankle joint. This decision was based
on the results of routine clinical assessments of spasticity by
means of Modified Ashworth scale (20) and Tardieu R1 angle
(21), ROM (bymeans of goniometry), strength and selectivity (by
means of manual muscle testing and clinical selectivity scores),
and a 3D gait analysis. Furthermore, included children had a
minimum of 20◦ ankle ROM in the most involved limb, no
behavioral problems that would impede the ability to understand
and perform the test procedure, and no dyskinesia, dystonic
or ataxic features. Children who received BoNT-A injections in
the calf muscles within 6 months prior to the first assessment,
a Selective Dorsal Rhizotomy (SDR), or orthopedic surgery
on the lower-leg, were excluded. Children with a Modified
Ashworth Scale score of 2 or higher in the hamstrings and psoas
muscles, indicating greater proximal compared to distal muscle
involvement (and therefore not suited to receive ankle stretching
casts without multilevel BoNT-A injections), were also excluded.
The local University Hospitals’ Ethics Committee (study number
s57384) approved this study. All participants were informed
on the content of the study and written informed consent for
participation was obtained from all parents/legal guardians and
children above the age of 12 years.
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Interventions
This investigation describes the first part of a larger study
including a crossover design whereby BoNT-A (Botox R©;
Allergan Ltd, Buckinghamshire, UK) and lower-leg casting were
applied in two treatment sessions, rather than during the same
session. The treatment sessions were separated by a two-week
period. This approach allowed investigation of the individual
effects of BoNT-A and casting at a group level, but also ensured
that all patients eventually received both of their prescribed
clinical treatments. Patients were randomly allocated by an
independent researcher to one of two groups by minimization
such that each allocation minimized imbalance between the
groups across multiple factors including Gross Motor Functional
Classification Scale (GMFCS) level, topographic classification
(unilateral or bilateral involvement), age, and gender. Children
allocated to the first group received BoNT-A in the MG as
part of their multi-level treatment. BoNT-A dosage and muscle
selection was based on patient weight, medical history, findings
of a clinical examination, 3D gait analysis, and the clinician’s
experience. Injection was given under short masked anesthesia,
and was ultrasound guided for visual identification of muscles
and needle depth.
Children allocated to the second group received two weeks of
lower-leg casting. Polyester casts were applied conform clinical
guidelines by a specialized nurse, supervised by the treating
orthopedic surgeon.
In the two weeks following treatment, children in both groups
continued with their usual post-treatment physical therapy.
Children allocated to the BoNT-A group continued their usual
use of their ankle-foot orthoses.
Assessments
Assessments were carried out on the most affected leg, defined
by the most recent clinical examination. In the case of equal
involvement, the left leg was assessed. Clinical examination
of the plantar flexors including the Modified Ashworth Scale
(20) and Tardieu R1 angle (21) as well as measurements of
body weight and height were carried out before the treatment.
Assessments of muscle and tendon lengths, ankle joint resistance
and stretch reflexes were carried out before, and two weeks after,
the individual treatments by the same experienced assessor.
Muscle and Tendon Lengths
Muscle and tendon lengths were assessed using 3D freehand
ultrasound (3DfUS); combining conventional B-mode 2D
ultrasound (Telemed EchoBlaster128, Vilnius, Lithuania) with
3Dmotion analysis (Optitrack NaturalPoint, USA), as previously
described (22). TheUS acquisition parameters were kept constant
between the different acquisitions (frequency, 10 MHz; depth,
5 cm; focus, 1.8–2.8 cm; gain, 46%; dynamic range, 44 dB
and unaltered time-gain compensation) (23). This method has
proven to be valid with a strong inter acquirer reliability in both
healthy and pathological muscles (23, 24).
Subjects lay prone with the lower-leg supported by a small
triangular cushion allowing ∼20◦ of knee flexion and the ankle
to rest comfortably over the edge of the cushion, to reduce bi-
articular stretch on the plantar flexor muscles. This position is
referred to as the resting ankle position. First, theMGwas imaged
at this resting ankle position. Secondly, imaging was carried out
with the ankle at maximum dorsiflexion. Maximum dorsiflexion
was achieved by a second examiner who manually fixated the
ankle in this position while ensuring that maximal motion
occurred at the subtalar joint, avoiding foot add-/abduction or
pro-/supination. The US images were recorded by an experienced
examiner starting from themedial femoral condyle until themost
distal edge of the calcaneus. Two 3DfUS sweeps over the MG
were carried out at each ankle position. The knee and ankle joint
angles were measured with a goniometer at both positions.
Instrumented Assessment of Ankle Joint Resistance
and Stretch Reflexes
A previously described assessment was used to distinguish
between neural and non-neural components of ankle joint
resistance during slow and fast passive joint rotations
that stretched the plantar flexors (25). Participants were
assessed supine with the lower-limb supported. Three inertial
measurement units (IMU’s) were used to track the movement
of the upper-leg with respect to the lower-leg and the lower-leg
with respect to foot. Calibration trials were carried out to define
a known angular position and the direction of rotation. A six
degrees-of-freedom torque load-cell (ATI mini45: Industrial
Automation), attached to a foot orthosis, was used to move the
ankle and measure the forces and moments applied to the ankle
(25). Surface electromyography (EMG) data (Zerowire, Cometa,
Milan, IT) were collected from the MG, lateral gastrocnemius,
soleus and tibialis anterior. With the subject fully relaxed, three
passive ankle rotations over the full ROM were performed, first
at slow velocity (5 s to complete full ROM) and then as fast as
possible. Between repeated rotations, there was at least a 7 s rest
interval, to avoid post-activation depression (26).
Data Processing
Muscle and Tendon Lengths
An open-source software library, developed in Python, was used
to create a 3-dimensional view of the MG by integrating 2D
US data and motion tracking (22). The 3D reconstruction of
the muscle-tendon complex was visualized in a custom-made
workflow in Mevislab (www.mevislab.de) (22). Visualization in
three planes allowed for accurate identification of the following
anatomical landmarks: the most superficial part of the femoral
condyle used to define the MG muscle origin; the muscle-
tendon junction (MTJ), as the muscle insertion and tendon
origin; and the most proximal point on the calcaneus as the
tendon insertion. The lengths of the MG and corresponding
tendon in the two ankle positions were extracted by calculating
the Euclidean distances between these landmarks (Figure 1).
Muscle-tendon complex length was calculated as the summation
of muscle (ML) and tendon length (TL). The same assessor,
who was blinded for group allocation and assessment session,
extracted all lengths twice. Average lengths were calculated and
used for the final statistical analysis. In addition, the standard
error of measurement (SEM) associated with extracting the
lengths was calculated from the square root of the mean square
error from one-way ANOVA (27). The change in joint angle,
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FIGURE 1 | Sagittal US image with landmarks for extraction of muscle and tendon length C, calcaneus; MTJ, muscle tendon junction; MFC, medial femoral condyle.
ML and TL between the two joint positions was calculated
and indicated the degree of the joint (1 ankle angle) and
muscle/tendon “extensibility.”
Instrumented Assessment of Ankle Joint Resistance
and Stretch Reflexes
Data collected during the ankle joint resistance assessment
were processed offline using a custom-made Matlab program
(Mathworks, R2015a) as previously described (25). Raw EMG
signals were filtered with a 6th order zero-phase Butterworth
bandpass filter from 20 to 500Hz. The root mean square
(rms) envelope of the EMG signal was defined by taking
the square root after applying a low-pass 30Hz 6th order
zero-phase Butterworth filter on the squared raw signal.
Joint angle and angular velocity were calculated from the
IMU data by applying a Kalman filter (28). The net ankle
joint moment was calculated from the forces and moments
applied on the load-cell, the external moment arms, and
the predicted torque caused by gravity on the orthotic
(25).
ROM and maximum angular velocity were extracted from
slow and fast passive ankle rotations. Average rms-EMG was
calculated during an interval 200ms before maximum velocity to
90% of the ROM, thereby emphasizing the velocity dependency
of the hyperactive stretch reflex and excluding the effects of end
ROM. To quantify the hyperactive stretch reflexes, average rms-
EMG during slow velocity rotations was subtracted from average
rms-EMG during fast rotations.
To quantify joint resistance, work during slow and fast passive
rotations was defined as the average area underneath the torque-
angle graph from maximum velocity to 90% ROM (25). Work
during the slow passive rotation represented the non-neural
component of joint resistance. The work during slow rotation
was subtracted from that during fast rotation to calculate the
neural component of joint resistance (25).
Statistical Analysis
An overview of the used statistical analyses is included
in Figure 2.
Statistical analyses were performed using SPSS statistics
(version 25 IBM). Normality of data distribution was evaluated
using the Kolmogorov-Smirnov test. Outlier analysis was
performed visually. Within-group treatment effects were
evaluated with Wilcoxon signed ranks tests. Between groups,
the treatment-induced changes were compared using Mann-
Whitney U-tests. In addition to being statistically significant,
treatment-induced changes were only considered meaningful
when larger than the SEM.
Associations between treatment-induced changes in ankle
angles, muscle/tendon lengths, extensibility, ankle joint hyper-
resistance and stretch reflex parameters were assessed by
Spearman rank correlation coefficients for both treatment groups
separately. Correlation values of 0.6 or higher were considered as
strong (29).
Effect sizes were calculated according the formula: r =
Z/
√
N (30). The Z-score was extracted from the SPSS
output of the Wilcoxon signed rank test. N represents the
total number of observations. R-values of 0.5 or higher were
considered as large effect sizes, whereas r-values above 0.3 were
considered moderate.
RESULTS
Thirty-one children with spastic CP (GMFCS I-III, age 7.4
± 2.6 years) were included in this investigation. During the
course of this study, some data were lost due to dropout and/or
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FIGURE 2 | Overview of statistical analyses. 3DfUS, 3D freehand ultrasound; BoNT-A, Botulinum NeuroToxin-A.
FIGURE 3 | Flowchart of the inclusion of participants with an overview of the available and missing data. 3DfUS, 3D freehand ultrasound; GMFCS, gross motor
functional classification scale; BoNT-A, Botulinum NeuroToxin-A.
technical issues with measurement equipment. The flowchart of
the patient enrolment and all available data that were included
in the final data analyses, and subdivided per outcome, are
presented in Figure 3. At baseline (Table 1), the two intervention
groups did not differ in age, body weight, height, maximum
dorsiflexion ankle angle, Modified Ashworth Scale, Tardieu
R1 angle, the difference in ankle angle between resting and
maximum dorsiflexion position (1 ankle angle), extensibility of
the muscle or tendon, muscle/tendon lengths, ROM, angular
velocity, hyperactive stretch reflexes, and work. The number of
included patients and their characteristics per sub-analysis are
included in Supplementary Table 1.
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TABLE 1 | Participant characteristics.
Casting (n = 14) BoNT-A (n = 17)
Age (years) 7 (5–8.3) 7 (5.5–10.5)
Body weight (kg) 23.6 (18.4–28.7) 25 (19–27.6)
GMFCS level I = 6, II = 6, III = 2 I = 11, II = 4, III = 2
Involvement Unilateral = 7, Bilateral = 7 Unilateral = 12, Bilateral = 5
Gender Male = 8, Female = 6 Male = 12, Female = 5
MAS*, knee extended 2 (1.5–3) 2 (1–3)
MTS R1*, knee extended (degrees) −12.5 (−35 to −5) −12.5 (−25 to 0)
Treatment details 2 weeks of lower-leg casting: n = 14
2 weeks of removable upper- leg casts worn during the
night: n = 3
BoNT-A (Botox®) plantar flexors: 4 Units/kg (2.33–6.12)
BoNT-A (Botox®) MG: 2.47 Units/kg (1.93–3.66)
BoNT-A (Botox®) LG: 0.37 Units/kg (0.00–0.71)
BoNT-A (Botox®) SOL: 1.49 Units/kg (0.00–2.04)
Use of day orthoses, prior to treatment Frequently used (≥50% of the day) n = 11
Not frequently used (<50% of the day) n = 1
Not used n = 2
Frequently used (≥50% of the day) n = 14
Not frequently used (<50% of the day) n = 1
Not used n = 2
Use of night orthoses, prior to treatment Frequently used (≥50% of the night) n = 2
Not frequently used (<50% of the night) n = 7
Not used n = 5
Frequently used (≥50% of the night) n = 2
Not frequently used (<50% of the night) n = 4
Not used n = 11
Values are presented as medians with corresponding quartiles (p25–p75), or numbers (n). *median, minimum-maximum values. BoNT-A, Botulinum NeuroToxin-A; GMFCS, Gross Motor
Functional Classification Scale; MAS, modified ashworth scale; MTS, modified tardieu scale; MG, medial gastrocnemius muscle; LG, lateral gastrocnemius muscle; SOL, soleus muscle.
Muscle and Tendon Lengths
There was a positive significant treatment effect of casting
on the resting (p = 0.004, pre median: −31.5◦, inter quartile
range (IQR): 20.0◦; post median: −25.0◦, IQR: 10.0◦, effect size
= 0.56) and maximum dorsiflexion (p = 0.026, pre median:
0.0◦, IQR: 3.8◦; post median: 10.0◦, IQR: 10.0◦, effect size =
0.44) angles (Figure 4). Knee angles remained constant between
the assessments of muscle/tendon lengths before and after
treatment. The SEM values for determining the muscle and
tendon lengths were 2.25 and 2.54mm, respectively. SEM values
were found to be comparable to those previously reported (23).
The absolute muscle and tendon lengths pre- and post-treatment
are presented in Figure 4 and the treatment-induced change
values are presented in Supplementary Table 2. Two weeks of
casting caused a significant increase in the TL andmuscle-tendon
complex length at maximum dorsiflexion (5.6%, p= 0.039, effect
size = 0.40, and 4.1%, p = 0.005, effect size = 0.63, respectively).
These treatment-induced changes were also significantly larger
than those found in the BoNT-A group (p = 0.002 and p =
0.001, respectively).
A significant increase in MG ML at the resting ankle position
was found after BoNT-A injections (6.9%, p= 0.013, effect size=
0.53). Additionally, a significant increase in the TL at maximum
dorsiflexion occurred, however this increase was within the range
of the SEM. At the resting ankle position, ML after BoNT-
A injections and the treatment-induced change in ML were
significantly larger compared to those assessed following casting
(p= 0.023 and p= 0.036, respectively).
Post-treatment, the extensibility of the ML and of the muscle-
tendon complex length were significantly reduced after BoNT-A
injections (−34.1%, p = 0.010, effect size = 0.55 and −36.3%,
p = 0.013, effect size = 0.56, respectively), but unaltered
by casting.
Instrumented Assessment of Ankle Joint
Resistance and Stretch Reflexes
The ankle joint ROM and angular velocities applied during
passive joint rotation remained unchanged after either treatment.
Effects of the treatments on plantar flexor stretch reflexes and
joint work are displayed in Figure 4. Two weeks of casting
caused a significant reduction in the stretch reflexes of the lateral
gastrocnemius (−29.5%, p = 0.047, effect size = 0.44), and
soleus (−17.5%, p = 0.034, effect size = 0.43). Post-casting, the
average work assessed during slow, and fast minus slow stretch
remained unchanged.
BoNT-A injections resulted in a significant reduction in the
stretch reflexes of the MG (−72.4%, p= 0.003, effect size= 0.56)
together with a reduction in work during fast minus slow stretch
(−22.4%, p = 0.013, effect size = 0.47). There was a trend that
this reduction in work was larger in the group receiving BoNT-A
compared to casting (p= 0.050).
Associations
Few correlations were found between the changes in joint
angles, muscle/tendon lengths and ankle joint resistance. An
overview of all correlation values and significance can be found
in Supplementary Tables 4, 5.
In the casting group, there was a moderate positive
correlation (r = 0.56, p = 0.049) between the change
in TL at maximum dorsiflexion and the change in ankle
angle (1 ankle angle). Additionally, the increase in TL at
maximum dorsiflexion was negatively related (r = −0.67, p
= 0.050) to the reduction in stretch reflexes in the lateral
gastrocnemius and the amount of work at high velocity (r
= −0.60, p = 0.03). Furthermore, the increase in muscle-
tendon complex length at rest was associated (r = −0.821,
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FIGURE 4 | Results of muscle/tendon lengths, ankle joint resistance and stretch reflex assessments. (A) Change in ankle angles. (B) Muscle and tendon lengths at
resting position. (C) Muscle and tendon lengths at maximum dorsiflexion. (D) Work at the ankle joint during slow and fast joint rotations. (E) Stretch reflexes of the
plantar flexors during fast rotations. *significant results (p < 0.05, difference > SEM). mm, millimeter; J, Joule; rms EMG, root mean square of the electromyographic
signal; µV, microvolt; MG, medial gastrocnemius muscle; LG, lateral gastrocnemius muscle; SOL, soleus muscle; BoNT-A, Botulinum NeuroToxin-A.
p = 0.02) with the reduction in stretch reflexes in the
lateral gastrocnemius.
In the BoNT-A group, the reduction in hyperactive stretch
reflexes of the soleus muscle was strongly correlated (r = 0.79,
p = 0.036) to the increase in ML of the MG at rest. In addition,
the reduction in work at fast minus slow velocity was strongly




The aim of this study was to gain more insight into the working
mechanisms of BoNT-A and casting at the joint andmuscle levels
in children with spastic CP. Our hypotheses that BoNT-A targets
the muscles’ stretch reflexes, whereas casting targets the muscle
belly and tendon length, were partly confirmed. Two weeks
of casting increased the dorsiflexion angle, lowered the stretch
reflexes in the lateral gastrocnemius and soleus muscles and
increased the tendon length measured at maximum dorsiflexion
position. BoNT-A reduced the stretch reflexes in theMG, reduced
the joint resistance measured during fast passive ankle joint
rotation, and increased the muscle length measured at the resting
ankle position. Only a few associations between the treatment-
induced alterations in joint angles, muscle or tendon lengths
and measures of ankle joint resistance, and stretch reflexes were
found. In summary, this study found rather minor changes at the
muscle level after either intervention, with limited relationships
between the effects at the joint, muscle or tendon lengths and
stretch reflexes.
Casting
We confirmed previous findings that maximum dorsiflexion
increases after lower-leg casting (31, 32). However, since the
joint angle at rest also moved toward greater dorsiflexion,
the total joint ROM and change in ankle angle (1 ankle
angle) remained unchanged after treatment. While this result
may make it easier to fit a foot into an ankle-foot orthosis
configured toward dorsiflexion, it remains unclear to what
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extent this new biomechanical configuration is functionally
useful. In the two subjects whose ROM did increase, this
was mainly explained by an increase in their maximum
dorsiflexion angle with an accompanied increased tendon length
(Supplementary Figure 1). Interestingly, the three children
who additionally received removable upper leg casts during
the night showed an increase in muscle belly length at
maximum dorsiflexion.
Since the plantar flexor muscles of children with spastic CP
have been described as stiff and short (33), lengthening of these
muscles through treatment is desirable. In clinical practice, it is
thereby commonly hypothesized that an increase in dorsiflexion
angle following casting is a result of lengthening the muscle.
However, our results showed that the increase in maximum
dorsiflexion angle post-casting was related to the increase in
tendon length rather than alterations in muscle belly length. Hösl
et al. (2015) reported increased tendon length following a period
of ankle foot orthotic use (34) and Theis et al. (2013) reported
similar results after a manual stretching intervention (35). As far
as we are aware, our study is the first to report this effect following
two weeks of casts.
Previous studies suggested that children with CP have a more
compliant Achilles tendon (36, 37). In ambulant children with
CP, this adaptation may be beneficial for achieving sufficient
dorsiflexion during the stance phase of gait, but may compromise
push-off power as the tendon may offer less resilience. Therefore,
given that TL is already increased in CP, our findings highlight
that caution has to be paid when applying passive stretches
due to potentially enhancing the negative effects on the tendon.
This is especially important when considering the coherence
of the muscle-tendon unit as a complex and the efficiency of
the muscle and tendon to interact during function. A recent
study by Kalkman et al. (2019) concluded that increased tendon
compliance in CP may result in reduced stretch stimulus to
the muscle during ankle rotation, thus explaining the minimal
effects of stretching interventions on muscle remodeling (38). In
a follow-up study, they then confirmed that initially increasing
tendon stiffness, by means of strength training, resulted in more
efficient muscle stretch (38). Similarly, the group of Zhao et al.
(2010) accomplished a reduction in Achilles tendon length and
increased stiffness by combining passive stretching with active
movement therapy (39). These findings suggest that stretching
should be combined with strengthening exercises in order to
optimally target the muscle belly.
The reduction in hyperactive stretch reflexes of the lateral
gastrocnemius and soleus following casting was unexpected, but
might be explained by the alteration in starting ankle angle, as the
ankle was spontaneouslymore dorsiflexed after casting.Meinders
et al. (1996) suggested that specifically at the ankle, stretch
reflexes are reduced at a longer starting muscle-tendon complex
lengths (40). Confirming this, we found that the reduction in
hyperactive stretch reflex in the lateral gastrocnemius following
casts was associated with an increase in tendon length.
BoNT-A
BoNT-A targets the neural component of ankle joint resistance
by reducing the hyperactive stretch reflexes. Reduction of
hyperactive stretch reflexes is thought to create the opportunity
for the muscle to act over a larger ROM and thereby improve
its function (41). Our results confirmed the reduction of MG
stretch reflexes, shown by a reduction in rms-EMG of the MG
and in the reduced work needed to move the ankle joint during a
high-velocity stretch of the plantar flexors. The question remains
whether these changes additionally translate to morphological
changes at the muscle level. Post BoNT-A, we observed an
increase in the resting length of the MG muscle belly. Since
spastic muscles have been described with a higher resting muscle
tone (42), the increased MG muscle belly length may be a direct
result of muscle tone reduction and the ability of the muscle to
relax in this position. On the other hand, there were no changes to
themuscle lengthmeasured atmaximumdorsiflexion. Therefore,
we found little evidence that the reduction in hyperactive stretch
reflex of the MG post BoNT-A induced muscle remodeling. It is
known that the muscle needs more time than the current short-
term (two weeks) follow-up to adapt and no conclusions can be
drawn about the medium- and long-term effect of BoNT-A on
muscle length (43). Furthermore, muscle remodeling might take
place after combining with casting.
Combined Treatment
Answers regarding the combination of the treatments are
currently being analyzed as the second part of this research
project, which includes a crossover design with all the
participants receiving the other treatment. In addition, this
second part includes 3D gait analysis before and after receiving
the two interventions allowing us to understand effects of the
interventions on the functional level. Desloovere et al. (2007)
showed that BoNT-A combined with casting was more effective
in improving gait, compared to casting alone (44). However,
it is unclear how these effects were achieved and additional
insight, which we expect to gain with the second stage of this
project, will likely facilitate the understanding of these findings.
Following BoNT-A injections only, there were no changes in
the ankle angles or joint ROM. Given the effects of casting
on these parameters, there is reason to believe that the best
results may be achieved when the two treatments are combined.
Ideally, the changes seen on the muscle level following BoNT-
A, in combination with static stretch as applied from casting,
will result in the desired effect of increasing the joints ROM by
promoting muscle length. Such an effect should result in greater
ankle mobility that would be transferrable to the child’s gait.
However, given the finding that casting only increased the tendon
length, very careful monitoring of how ankle mobility is achieved
post-casting is essential, as it may be subject-specific. This
highlights that an individualized and fine-tuned combination
of the treatments is required. Furthermore, we can question
whether a primarily passive stretch applied by casts is beneficial,
as evidence shows that muscle activity is required to efficiently
stretch the muscle and maintain an optimal configuration of the
muscle-tendon complex (39).
Importantly, since neither treatment in isolation affected the
increased joint resistance assessed during slow passive stretch, it
is unlikely that the combination of the two treatments will affect
resistance during slow stretch. If confirmed, this suggests that
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we need more effective treatments that address hyper-resistance
over the full ROM, and not only increases the maximum
dorsiflexion. If combined results are still not satisfactory, new
treatment modalities should be developed to more efficiently
target the muscle.
Our data showed a lack of strong responses on the group
level. This reflects the large heterogeneity of the children with
CP included in this study and therefore the need for larger
samples. Given that the sample was taken from the clinical
population seeking treatment for ankle joint hyper-resistance,
this finding emphasizes the need to generate muscle-specific
profiles and establish patient-tailored treatment. Furthermore,
we highlight the importance of evaluating the underlying muscle
and tendon structures rather than providing treatment based
only on conclusions drawn from evaluations at the joint level.
Limitations
The study has limitations that need to be acknowledged.
This study investigated only the very short-term effects of
the treatments. This allowed us to evaluate the separate
effects without having to compromise on the children’s clinical
intervention plan. A study design in which the same study sample
received both treatments including a wash-out period would
have been methodically stronger. However, implementing such
an investigation would differ too much from normal clinical
treatment and would not be considered ethical (nor would
including control groups from whom treatment was denied). In
addition, considering the long time span of such a study, other
parameters would influence the response.
This clinical study included a small dataset with missing
data. As a result, not all participants were included in all
analyses. When only including subjects who underwent both
assessments (n = 23, BoNT-A n = 9, casting n = 13), most
of our conclusions were still valid (Supplementary Table 3).
Nevertheless, more studies need to be conducted to confirm
the initial results of this study. Randomization by minimization
was applied in order to minimize differences between groups in
terms of pathology, age, body weight and height. Even though
the groups did not perfectly match, there were no differences
reported at baseline. Heterogeneity in treatment history and
current treatment adherence are limitations when performing
randomized controlled trials in children with CP. It is well-
described that muscle morphology of children with CP is
different from typically developing peers, although it remains
unclear to what extent treatment history contributes to these
alterations. This should be focus for further investigation. In
addition, given the wide age range, and the effect of age on the
ability of the muscle fiber to adapt, it is possible that the muscle
fiber stage influenced our results.
The full data set of this investigation is published (DOI:
https://doi.org/10.6084/m9.figshare.12009375.v1). When more
data becomes available, sub analyses according to baseline
characteristics may be carried out that will contribute to
clinical implementation.
This study only investigated the muscle and tendon lengths
of the MG as this is the muscle that is most frequently treated
with BoNT-A in daily clinical practice. Future investigations
with larger samples investigating more muscles are needed to
confirm these initial findings. Given recent validation of the
clinical applicability of the methods used in this study (23, 45),
such investigations should be feasible in the near future.
We studied the alterations in the length of the entire muscle
belly. Yet, this does not provide information on the fascicle
behavior, especially since the MG is pennated. More-over, local
fascicle remodeling in specific regions of the muscle may have
occurred. Furthermore, since neither muscle length nor fascicle
length necessarily represent sarcomere number or length, it is
important to continue investigations that combine macro- and
micro-structure responses to the applied treatments.
CONCLUSION
This study presents initial findings on treatment response in a
heterogeneous group of children with spastic CP. Intramuscular
BoNT-A injections reduced the stretch reflex in the MG
accompanied by an increase in resting muscle belly length,
whereas casting resulted in increased dorsiflexion without any
changes to the muscle length. These results indicate limited
treatment-induced MG muscle remodeling. This supports the
need for further investigation once the treatments are combined
and for the development of treatments that more effectively
lengthen the muscle belly. Additionally, future implementation
of objective assessments will contribute to a better understanding
of treatment effects, which could support clinical decision-
making and help to identify responders.
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